Oakleigh Folkes, PhD
Postdoctoral Fellow
Research & Publications
Biography
Coauthors
Selected Publications
- An endocannabinoid-regulated basolateral amygdala-nucleus accumbens circuit modulates sociabilityFolkes OM, Báldi R, Kondev V, Marcus DJ, Hartley ND, Turner BD, Ayers JK, Baechle JJ, Misra MP, Altemus M, Grueter CA, Grueter BA, Patel S. An endocannabinoid-regulated basolateral amygdala-nucleus accumbens circuit modulates sociability. Journal Of Clinical Investigation 2020, 130: 1728-1742. PMID: 31874107, PMCID: PMC7108917, DOI: 10.1172/jci131752.
- α2A-adrenergic heteroreceptors are required for stress-induced reinstatement of cocaine conditioned place preferencePerez RE, Basu A, Nabit BP, Harris NA, Folkes OM, Patel S, Gilsbach R, Hein L, Winder DG. α2A-adrenergic heteroreceptors are required for stress-induced reinstatement of cocaine conditioned place preference. Neuropsychopharmacology 2020, 45: 1473-1481. PMID: 32074627, PMCID: PMC7360592, DOI: 10.1038/s41386-020-0641-z.
- Role of Striatal Direct Pathway 2-Arachidonoylglycerol Signaling in Sociability and Repetitive BehaviorShonesy BC, Parrish WP, Haddad HK, Stephenson JR, Báldi R, Bluett RJ, Marks CR, Centanni SW, Folkes OM, Spiess K, Augustin SM, Mackie K, Lovinger DM, Winder DG, Patel S, Colbran RJ. Role of Striatal Direct Pathway 2-Arachidonoylglycerol Signaling in Sociability and Repetitive Behavior. Biological Psychiatry 2017, 84: 304-315. PMID: 29458998, PMCID: PMC6023784, DOI: 10.1016/j.biopsych.2017.11.036.
- Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivoBermingham DP, Hardaway JA, Snarrenberg CL, Robinson SB, Folkes OM, Salimando GJ, Jinnah H, Blakely RD. Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivo. Neurochemistry International 2016, 98: 122-128. PMID: 26850478, PMCID: PMC4969213, DOI: 10.1016/j.neuint.2016.01.008.
- Antioxidant Supplementation Ameliorates Molecular Deficits in Smith-Lemli-Opitz SyndromeKorade Z, Xu L, Harrison FE, Ahsen R, Hart SE, Folkes OM, Mirnics K, Porter NA. Antioxidant Supplementation Ameliorates Molecular Deficits in Smith-Lemli-Opitz Syndrome. Biological Psychiatry 2013, 75: 215-222. PMID: 23896203, PMCID: PMC3874268, DOI: 10.1016/j.biopsych.2013.06.013.
- Behavioral and serotonergic response changes in the Dhcr7-HET mouse model of Smith–Lemli–Opitz syndromeKorade Z, Folkes OM, Harrison FE. Behavioral and serotonergic response changes in the Dhcr7-HET mouse model of Smith–Lemli–Opitz syndrome. Pharmacology Biochemistry And Behavior 2013, 106: 101-108. PMID: 23541496, DOI: 10.1016/j.pbb.2013.03.007.